π§¬πβ οΈ Lenalidomide 10mg Tablet: A Targeted Therapy for Blood Cancers & Beyond
Lenalidomide 10mg is an immunomodulatory and anti-neoplastic agent, primarily used in the treatment of certain blood cancers and bone marrow disorders. It is structurally related to thalidomide but has enhanced potency and a more favorable safety profile. Lenalidomide works by modifying the immune system, suppressing tumor growth, and inhibiting abnormal cell proliferation, making it a valuable medication in modern hematologic oncology.
It is prescription-only, typically used under the supervision of an oncologist or hematologist.
π¬ Mechanism of Action
Lenalidomide has a multi-faceted mechanism:
-
Immunomodulation: Enhances T-cell and natural killer (NK) cell activity to attack cancer cells.
-
Anti-angiogenic effect: Inhibits new blood vessel formation in tumors, starving them of nutrients.
-
Direct cytotoxic action: Kills malignant cells in multiple myeloma and myelodysplastic syndromes (MDS).
-
Alters cytokine production, reducing inflammation and disease progression.
π Indications and Uses
Lenalidomide 10mg is used in:
π§ͺ Blood Cancers
-
Multiple Myeloma (MM): In combination with dexamethasone or other agents for newly diagnosed and relapsed cases.
-
Myelodysplastic Syndromes (MDS): Especially those with deletion 5q cytogenetic abnormality.
-
Mantle Cell Lymphoma (MCL): For patients who have received at least one prior therapy.
-
Chronic Lymphocytic Leukemia (CLL): In clinical trials and select treatment protocols.
π Dosage and Administration
-
Dose varies by indication, commonly 10β25mg once daily.
-
For MDS, typically 10mg once daily until disease progression or unacceptable toxicity.
-
Administered in 28-day cycles (21 days on, 7 days off).
-
Take with or without food, preferably at the same time each day.
β οΈ Precautions and Warnings
-
Pregnancy Risk: Category X β Strictly contraindicated in pregnancy due to severe birth defects.
-
Requires enrollment in REMS (Risk Evaluation and Mitigation Strategy) program.
-
Males and females of childbearing potential must use effective contraception.
Use cautiously in patients with:
-
Renal impairment (dose adjustment needed)
-
Thromboembolic risk (may require blood thinners)
-
Infection risk (due to immunosuppression)
Regular monitoring of blood counts is mandatory.
π€ Common Side Effects
-
Fatigue
-
Diarrhea or constipation
-
Low white blood cell (neutropenia) or platelet count (thrombocytopenia)
-
Skin rash or itching
-
Increased risk of blood clots (deep vein thrombosis, pulmonary embolism)
Serious side effects:
-
Severe bone marrow suppression
-
Liver function changes
-
Secondary malignancies (rare)
-
Hypothyroidism
Discontinue immediately in case of allergic reaction or severe toxicity.
π Drug Interactions
-
Risk of blood clots increases when used with dexamethasone, erythropoietin, or hormone therapy
-
May interact with anticoagulants β monitor INR closely if on warfarin
-
Use caution with live vaccines due to immunosuppression
π§ Storage and Handling
-
Store at 20β25Β°C, away from moisture and light
-
Do not crush or open capsules
-
Handle with gloves if you are not the patient
-
Keep out of reach of children and pregnant women
π Conclusion
Lenalidomide 10mg is a life-extending medication for patients with multiple myeloma, MDS, and lymphomas, working through immune modulation and direct anti-cancer activity. Its powerful benefits come with serious safety responsibilities, especially regarding pregnancy and bone marrow suppression. When used carefully, it plays a crucial role in modern hematologic cancer therapy, often improving survival and quality of life.
Always follow your doctorβs advice, dosage instructions, and never self-medicate.
Note: This information is intended for educational purposes and should not replace professional medical advice. Always consult your healthcare provider for personalized recommendations.





Reviews
There are no reviews yet.